INDIANAPOLIS - Eli Lilly and Company (NYSE: NYSE:LLY), a pharmaceutical giant with a market capitalization of $783.7 billion ...

Eli Lilly presents positive results from VIVID-2 open-label extension study of Omvoh to treat Crohn's disease at Crohn's and Colitis Congress: Indianapolis Monday, February 10, 20 ...

Eli Lilly has raised its revenue guidance for ... In its update, Ricks said a new facility at Concord in North Carolina – part of an $18 billion investment programme launched in 2020 – is ...

Eli Lilly(NYSE: LLY) began a roll in late 2020 that lasted almost ... although Novo Nordisk has some manufacturing capacity in Clayton, North Carolina. It's likely, therefore, that steep tariffs on ...